about
BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression.Cyclosporine versus tacrolimus: cost-effectiveness analysis for renal transplantation in Brazil.Haematuria in postrenal transplant patients.Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipientsPossible antiviral effect of ciprofloxacin treatment on polyomavirus BK replication and analysis of non-coding control region sequences.Immunosuppressive agents as risk factors for BK virus nephropathy: an overview and update.Management of polyomavirus-associated nephropathy in renal transplant recipients.Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms.Opportunistic infections complicating solid organ transplantation with alemtuzumab induction.Sex differences in transplantation.Incidence and outcome of BK polyomavirus infection in a multicenter randomized controlled trial with renal transplant patients receiving cyclosporine-, mycophenolate sodium-, or everolimus-based low-dose immunosuppressive therapy.Screening for latent BK virus infection in a renal transplant population for the first time in Romania: a single-center experience.Incidence of BK polyomavirus infection after kidney transplantation is independent of type of immunosuppressive therapy.Correlation between the presence of degenerated inclusion-bearing cells in voided urine samples and the occurrence of polyomavirus infection.Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation.JC polyomavirus nephropathy confirmed by using an in-house polymerase chain reaction method.Urinary decoy cell grading and its clinical implicationsAssociation of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor.BK polyomavirus in solid organ transplantation.Test performance characteristics of quantitative nucleic acid testing for polyomaviruses in kidney and kidney-pancreas transplant recipients.Cyclosporine versus tacrolimus in immunosuppressive maintenance regimens in renal transplants in Brazil: survival analysis from 2000 to 2004.Genotypic diversity of polyomaviruses circulating among kidney transplant recipients in Kuwait.BK virus viremia in a well-HLA-matched kidney transplant population mainly on low-dose cyclosporine-based immunosuppression.The case of BK virus infection in which it was difficult to differentiate from acute rejection.Absence of JC polyomavirus (JCPyV) viremia in early post-transplant JCPyV nephropathy: A case report.Safety profile comparing azathioprine and mycophenolate in kidney transplant recipients receiving tacrolimus and corticosteroids.Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients.
P2860
Q35099077-4FF44538-17C5-4BB1-806E-03A6A1629399Q35281597-829BF269-D4CF-4F4E-ABA1-B5F3F9A13788Q35401835-41131604-6CF3-40BE-9A3A-82A80332B554Q36126901-C5C18224-079D-4AD9-A98B-AAB5B1F5B64EQ37155134-70B6B5AC-D73D-42E6-9160-DA5B083EABC4Q37762535-CDB8783F-7D0A-4B95-ADE0-F6A19F427F1FQ38003050-1A40AC2E-8482-48AE-BB17-9FCA60855FE4Q38061056-175D69D6-C49D-495C-93EA-6F890CBE428BQ38558078-849DCCE7-3A14-4DA3-9838-180ABF11485DQ38750337-7C15477F-9F0A-4718-811B-3C40EAA7C6FEQ38930188-2EA8043D-FB46-4F62-B191-E3C0E836E60EQ39759053-34AA302A-DF69-4FA6-BCD6-2EC74FC78805Q40537031-437FF79D-5811-4A15-8B69-B7BA1A48519BQ40584647-9B356FD6-0D39-4EDE-A92C-8171571BE616Q40659387-554A6260-BDB7-444C-84AF-5D62942DC6FFQ41019245-F4DBFAD7-19FA-4DE6-A449-9AC68339F296Q41087673-32FBB723-9596-48C0-9333-471100DFC997Q42143824-BFD81A2E-0D2C-435C-B6ED-BB54FB29CCE1Q42261773-1A6C896F-0828-4269-9737-85FA6FE44D30Q42272314-6A8D3CC4-6E4E-4266-A83E-D00CE1FC845AQ42276202-7234D328-1EDD-4CF8-8786-52F344727D34Q43222628-19E9B4F9-4103-4420-BD0D-3B540CA88C98Q44743039-9B20F4F3-933A-43D5-A5F9-17AD2F8CA0C9Q45354262-9B575D8C-E2ED-4E34-8D9A-1F2A7E7CE85EQ45366112-B8C907E8-AA5D-41CE-854C-4DE1EF76F456Q47673367-5C4352D1-8B17-437A-9798-7180D62C7E1AQ51873726-E5E0D5C4-3079-4B4E-BC69-5099A3B7075CQ54590640-2E8BA293-93C3-4FEB-946E-C94CF374F445
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk factors for polyoma virus nephropathy
@en
Risk factors for polyoma virus nephropathy.
@nl
type
label
Risk factors for polyoma virus nephropathy
@en
Risk factors for polyoma virus nephropathy.
@nl
prefLabel
Risk factors for polyoma virus nephropathy
@en
Risk factors for polyoma virus nephropathy.
@nl
P2093
P2860
P356
P1476
Risk factors for polyoma virus nephropathy
@en
P2093
Jürg Steiger
Lukas Bubendorf
Michael Dickenmann
Michael J Mihatsch
Olivier Prince
Spasenija Savic
P2860
P304
P356
10.1093/NDT/GFN671
P407
P577
2008-12-10T00:00:00Z